Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
В Москве 11 апреля 2012 г. состоялость заседание экспертного совета по применению нового ингибитора дипептидилпептидазы-4 (ДПП-4) ТРАЖЕНТА (линаглиптин) в лечении сахарного диабета 2 типа (СД2). Планируется, что препарат уже осенью станет доступен для пациентов....
Saved in:
| Main Author: | Editorial team Diabetes Mellitus |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2012-06-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5527 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Russian Association of Endocrinologists reports commencement of Trajenta clinical use
by: Editorial team Diabetes Mellitus
Published: (2012-12-01) -
Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma
by: Dongyuan Su, et al.
Published: (2025-07-01) -
New prospects in the treatment of diabetes mellitus
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2012-12-01) -
Expert committee on introduction of incretin-based therapy in Russia: advance and failure
by: Editorial team Diabetes Mellitus
Published: (2012-09-01) -
National Council of Experts: the place of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus
by: M. V. Shestakova, et al.
Published: (2023-12-01)